These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29184680)

  • 1. Stereotactic body radiotherapy for locally-advanced unresectable pancreatic cancer-patterns of care and overall survival.
    Dohopolski MJ; Glaser SM; Vargo JA; Balasubramani GK; Beriwal S
    J Gastrointest Oncol; 2017 Oct; 8(5):766-777. PubMed ID: 29184680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
    Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
    Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta-analysis.
    Tchelebi LT; Lehrer EJ; Trifiletti DM; Sharma NK; Gusani NJ; Crane CH; Zaorsky NG
    Cancer; 2020 May; 126(10):2120-2131. PubMed ID: 32125712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant treatment strategies for resectable pancreas cancer: A propensity-matched analysis of the National Cancer Database.
    Xiang M; Heestand GM; Chang DT; Pollom EL
    Radiother Oncol; 2020 Feb; 143():101-107. PubMed ID: 32044168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer.
    Andruska N; Fischer-Valuck BW; Agabalogun T; Carmona R; Brenneman RJ; Huang Y; Gay HA; Michalski JM; Baumann BC
    Clin Genitourin Cancer; 2022 Apr; 20(2):123-131. PubMed ID: 35086762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of survival with stereotactic body radiation therapy following induction chemotherapy for unresected locally advanced pancreatic cancer.
    Ma SJ; Serra LM; Bartl AJ; Han HR; Fekrmandi F; Iovoli AJ; Prezzano KM; Hermann GM; Yu H; Singh AK
    J Radiother Pract; 2022 Sep; 21(3):403-410. PubMed ID: 36016862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer.
    Wu G; Baine MJ; Zhao N; Li S; Li X; Lin C
    BMC Cancer; 2019 Oct; 19(1):977. PubMed ID: 31640607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer.
    Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS
    Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer.
    Wang SC; Ting WC; Chang YC; Yang CC; Lin LC; Ho HW; Chu SS; Lin YW
    Front Oncol; 2020; 10():814. PubMed ID: 32547949
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer.
    Ma SJ; Prezzano KM; Hermann GM; Singh AK
    Radiat Oncol; 2018 Nov; 13(1):214. PubMed ID: 30400962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.
    Herman JM; Chang DT; Goodman KA; Dholakia AS; Raman SP; Hacker-Prietz A; Iacobuzio-Donahue CA; Griffith ME; Pawlik TM; Pai JS; O'Reilly E; Fisher GA; Wild AT; Rosati LM; Zheng L; Wolfgang CL; Laheru DA; Columbo LA; Sugar EA; Koong AC
    Cancer; 2015 Apr; 121(7):1128-37. PubMed ID: 25538019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
    Jacobs CD; Gao J; Wang X; Clarke JM; Tong B; Ready NE; Suneja G; Kelsey CR; Torok JA
    Clin Lung Cancer; 2020 May; 21(3):238-246. PubMed ID: 31757764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy versus conventional radiotherapy for early-stage small cell lung cancer.
    Newman NB; Sherry AD; Byrne DW; Osmundson EC
    J Radiat Oncol; 2019 Jun; 8(2):239-248. PubMed ID: 31402969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consolidatory ablative stereotactic body radiation therapy after induction chemotherapy for unresectable pancreatic cancer: A single center experience.
    Lee HI; Kang HC; Chie EK
    Front Oncol; 2022; 12():974454. PubMed ID: 36505838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer.
    Moningi S; Lei X; Fang P; Taniguchi CM; Holliday EB; Koay EJ; Koong AC; Ludmir EB; Minsky BD; Das P; Giordano SH; Smith GL
    Clin Transl Radiat Oncol; 2022 Jul; 35():9-16. PubMed ID: 35510142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant stereotactic body radiation therapy for nonmetastatic pancreatic adenocarcinoma.
    Jiang W; Haque W; Verma V; Butler EB; Teh BS
    Acta Oncol; 2019 Sep; 58(9):1259-1266. PubMed ID: 31237185
    [No Abstract]   [Full Text] [Related]  

  • 17. Stereotactic Body Radiotherapy as an Effective Treatment for Pancreatic Cancer.
    Hurmuz P; Cengiz M; Ozyigit G; Yuce Sari S; Kahvecioglu A; Beduk Esen CS; Yalcin S; Zorlu F
    Cureus; 2023 Apr; 15(4):e38255. PubMed ID: 37252548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of stereotactic body radiotherapy in advanced pancreatic cancers in Australia.
    Kim L; Nguyen N; Singhal N; Phan VA; Iankov I; Le H
    J Med Radiat Sci; 2019 Mar; 66(1):54-61. PubMed ID: 30411540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study).
    Comito T; Massaro M; Teriaca MA; Franzese C; Franceschini D; Navarria P; Clerici E; Di Cristina L; Bertolini A; Tomatis S; Reggiori G; Bresolin A; Bozzarelli S; Rimassa L; Bonifacio C; Carrara S; Santoro A; Zerbi A; Scorsetti M
    Curr Oncol; 2023 Jul; 30(7):7073-7088. PubMed ID: 37504373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid.
    Wegner RE; Abel S; Horne ZD; Hasan S; Colonias A; Verma V
    Lung Cancer Manag; 2019 Aug; 8(3):LMT14. PubMed ID: 31807142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.